• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yamamoto Takehito  山本 健人

ORCIDConnect your ORCID iD *help
Researcher Number 10909310
Other IDs
Affiliation (Current) 2025: 公益財団法人田附興風会, 医学研究所北野病院 腫瘍研究部, 研究員
Affiliation (based on the past Project Information) *help 2021 – 2023: 公益財団法人田附興風会, 医学研究所 腫瘍研究部, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / 0901:Oncology and related fields
Keywords
Principal Investigator
線維芽細胞増殖因子受容体 / FGFR阻害薬 / 大腸癌 / 分子標的治療薬 / 化学療法 / 線維芽細胞増殖因子 / FGFR / 線維芽細胞増殖因子受容体阻害薬 / スフェロイド / 癌幹細胞
  • Research Projects

    (2 results)
  • Research Products

    (4 results)
  •  Clinical Impact of the FGFR Gene on the Sensitivity to Novel Molecularly Targeted Therapeutics in Colorectal CancerPrincipal Investigator

    • Principal Investigator
      山本 健人
    • Project Period (FY)
      2023 – 2027
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      The Tazuke Kofukai
  •  Development of Predictive Markers for Sensitivity to Fibroblast Growth Factor Receptor Inhibitors Using Colorectal Cancer Stem CellsPrincipal Investigator

    • Principal Investigator
      Yamamoto Takehito
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      The Tazuke Kofukai

All 2024 2022

All Journal Article Presentation

  • [Journal Article] Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors2022

    • Author(s)
      Shoichi Kitano, Takehito Yamamoto, Makoto Mark Taketo
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 11 Pages: 4005-4010

    • DOI

      10.1111/cas.15523

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K20818
  • [Presentation] 大腸癌に対する線維芽細胞増殖因子受容体(FGFR)阻害薬の感受性診断を可能にする新規バイオマーカーの探索2024

    • Author(s)
      山本健人
    • Organizer
      第124回日本外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-23K14665
  • [Presentation] 腸癌患者由来の癌幹細胞スフェロイドを用いたFGFR阻害薬感受性スクリーニング2022

    • Author(s)
      山本健人、北野翔一、武藤誠
    • Organizer
      第26回日本がん分子標的治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-21K20818
  • [Presentation] fficacy evaluation of an FGFR inhibitor, a novel targeted drug, using patient-derived cancer stem cell spheroids for colorectal cancer patients2022

    • Author(s)
      Takehito Yamamoto, Makoto Taketo, Shoichi Kitano
    • Organizer
      Asian Oncology Society (AOS)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K20818

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi